Cresilon
Cresilon is a Brooklyn-based biotech company dedicated to saving lives through innovative hemostatic solutions. Their mission is to provide safe, effective, and reliable products that stop bleeding quickly, utilizing plant-based technology to revolutionize wound care in both veterinary and human medicine.
Industries
Nr. of Employees
small (1-50)
Cresilon
Patents
In-situ cross-linkable polymeric compositions and methods thereof
2022-07-12 • US-11383005-B2
View DetailsIn-situ cross-linkable polymeric compositions and methods thereof
2020-12-01 • US-10850003-B2
View DetailsIn-situ cross-linkable polymeric compositions and methods thereof
2017-06-27 • US-9687584-B1
View Details
In-situ cross-linkable polymeric compositions and methods thereof
2022-07-12 • US-11383005-B2
View DetailsIn-situ cross-linkable polymeric compositions and methods thereof
2020-12-01 • US-10850003-B2
View DetailsIn-situ cross-linkable polymeric compositions and methods thereof
2017-06-27 • US-9687584-B1
View DetailsProducts
VETIGEL (veterinary hemostatic gel)
Single-use, prescription hemostatic gel supplied in sterile pre-filled syringes for veterinary use; designed to control bleeding by forming a mechanical barrier on contact.
TRAUMAGEL (human-use trauma hemostatic gel)
Single-use, sterile hemostatic gel supplied in pre-filled syringes for temporary external use to control moderate to severe bleeding; described as FDA-cleared for use by licensed medical professionals in the US.
VETIGEL (veterinary hemostatic gel)
Single-use, prescription hemostatic gel supplied in sterile pre-filled syringes for veterinary use; designed to control bleeding by forming a mechanical barrier on contact.
TRAUMAGEL (human-use trauma hemostatic gel)
Single-use, sterile hemostatic gel supplied in pre-filled syringes for temporary external use to control moderate to severe bleeding; described as FDA-cleared for use by licensed medical professionals in the US.
Expertise Areas
- Hemostatic product development
- Biomanufacturing (GMP) and aseptic fill/finish
- Medical device regulatory submissions and compliance (FDA 510(k) / clearances)
- Preclinical bleeding-model research and translational R&D
Key Technologies
- Plant-derived polysaccharide polymers
- Flowable hemostatic gel
- Prefilled sterile syringe delivery
- Aseptic fill-and-finish manufacturing
Key People
News & Updates
An interview with Joe Landolina discussing the impact of Cresilon's innovations in hemostatic technology.
Coverage of the FDA approval for TRAUMAGEL, highlighting its potential to save lives in emergency situations.
A report on TRAUMAGEL and its expected impact on emergency care and trauma treatment.
Cresilon received FDA clearance for TRAUMAGEL, a hemostatic gel designed to stop severe bleeding in seconds.
An interview with Joe Landolina discussing the impact of Cresilon's innovations in hemostatic technology.
Coverage of the FDA approval for TRAUMAGEL, highlighting its potential to save lives in emergency situations.
A report on TRAUMAGEL and its expected impact on emergency care and trauma treatment.
Cresilon received FDA clearance for TRAUMAGEL, a hemostatic gel designed to stop severe bleeding in seconds.